Yang Nan, Jiao Mengwen, Zhang Yuewen, Mo Shaokang, Wang Ling, Liang Jianqing
School of Basic Medical, Gansu University of Chinese Medicine, Lanzhou, China.
School of Public Health, Gansu University of Chinese Medicine, Lanzhou, China.
Front Oncol. 2024 Jul 15;14:1430051. doi: 10.3389/fonc.2024.1430051. eCollection 2024.
Circular RNAs (circRNAs) constitute a class of endogenous non-coding RNAs (ncRNAs) that lack a 5'-ended cap and 3'-ended poly (A) tail and form a closed ring structure with covalent bonds. Due to its special structure, circRNA is resistant to Exonuclease R (RNaseR), making its distribution in the cytoplasm quite rich. Advanced high-throughput sequencing and bioinformatics methods have revealed that circRNA is highly conserved, stable, and disease- and tissue-specific. Furthermore, increasing research has confirmed that circRNA, as a driver or suppressor, regulates cancer onset and progression by modulating a series of pathophysiological mechanisms. As a result, circRNA has emerged as a clinical biomarker and therapeutic intervention target. This article reviews the biological functions and regulatory mechanisms of circRNA in the context of respiratory cancer onset and progression.
环状RNA(circRNAs)是一类内源性非编码RNA(ncRNAs),它们缺乏5'端帽和3'端多聚(A)尾,并通过共价键形成闭环结构。由于其特殊结构,circRNA对核酸外切酶R(RNaseR)具有抗性,使其在细胞质中的分布相当丰富。先进的高通量测序和生物信息学方法显示,circRNA高度保守、稳定,且具有疾病和组织特异性。此外,越来越多的研究证实,circRNA作为驱动因子或抑制因子,通过调节一系列病理生理机制来调控癌症的发生和发展。因此,circRNA已成为一种临床生物标志物和治疗干预靶点。本文综述了circRNA在呼吸道癌发生和发展过程中的生物学功能及调控机制。